Investors fled the company's stock in 2024 as a slow US launch of Leqembi, the Alzheimer's disease drug it sells with Japan's ...

Sanofi-backed Abcuro has secured $200 million in series C funds to power its anti-KLRG1 antibody through a phase 2/3 muscle ...

Just a few months after Vir Biotechnology lost an emergency authorization for its COVID-19 antibody, Marianne de Backer ...

Pocono Mountains United Way and Monroe County Transit Authority are partnering to provide free transportation services to people who do not meet the requirements of MCTA’s existing assistance ...

AdvanCell is developing therapies to treat cancers including: prostate, skin, pancreatic, breast, bladder, colorectal, kidney ...

Amazon Music and WPP unveiled Louder Than Cancer, an effort uniting top global artists to harness the power of music in recognition of World Cancer Day with creative leadership from WPP’s Grey Health, ...

Bruno Laforge joins Renault Group as Chief Human Resources Officer Boulogne-Billancourt, February 10, 2025 – Renault Group ...

Funding was led by New Enterprise Associates, with participation from Foresite Capital and multiple other investors.

New Division Empowers European Advertisers and Publishers with Cutting-Edge Tools and Data Technology to Thrive in the New ...

Sanofi's Sarclisa has been an also-ran in the ... At JP Morgan last month, pharmaphorum caught up with Paul Hastings, the CEO of Nkarta, to talk about NK cells and autoimmune diseases.

Life sciences trade association BioNJ has announced the election of its 2025 Officers and Board Members in concert with BioNJ ...